Abstract 75P
Background
A parallel deep learning network framework for whole-body bone scan image analysis Whole-body bone scan image analysis in nuclear medicine is a common method assisting physicians in bone metastases detection of cancer. As the increasing need for diagnostic examinations in the huge and elderly population in China, physicians are facing a significant growth of workload but must still manage to read the diagnostic images carefully and avoid errors in interpretation. It is crucial to develop a clinical decision support tool in assisting physicians in their clinical routine.
Methods
In this study, we proposed a parallel deep learning network framework for bone-scan interpretations of the presence or absence of bone metastases. The whole-body bone scans (anterior and posterior views) of 707 patients who are suspected bone metastatic disease were studied. The physicians were asked to classify each case for the presence or absence of bone metastasis manually. Each bone scan image was automatically segmented into 26 different anatomical regions of homogeneous bones based on the skeletal frame. The corresponding 26 deep learning networks made a diagnosis by inspecting each region and searching for abnormal lesion activity simultaneously. To estimate the performance of each anatomical sub-region identification models, a ten-fold cross testing scheme was applied where the data set was divided into ten parts of equal size randomly.
Results
The sensitivity, specificity and the mean number of false lesions detected were adopted as performance indices to evaluate the proposed model. The best sensitivity and specificity of an individual network corresponding to each sub-region are 99.9 % and 97.3% respectively. The overall mean sensitivity and specificity of the parallel model are 99.2% and 71.8% respectively, as well as 2.0 false detections per patient scan image within millisecond.
Conclusions
With an extremely high sensitivity, specificity and a low false lesions detection rate, this proposed parallel deep learning network model is demonstrated as useful for detecting metastases in bone scans. Our proposed framework appears to have significant potential as a clinical decision support tool in assisting physicians in their clinical routine.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
X. Pu: Full / Part-time employment: University of Electronic Science and Technology of China; Full / Part-time employment: University of Electronic Science and Technology of China; Full / Part-time employment: University of Electronic Science and Technology of China. G. Tang: Full / Part-time employment: West China University Hospital, Sichuan University. K. Cai: Research grant / Funding (institution): School of Computer Science and Engineering, University of Electronic Science and Technology of China. Y. Huang: Research grant / Funding (institution): College of Computer Science, Sichuan University. M. Ping: Research grant / Funding (institution): School of Computer Science and Engineering, University of Electronic Science and Technology of China. Z. Peng: Research grant / Funding (institution): Big Data Research Center, University of Electronic Science and Technology of China. H. Qiu: Full / Part-time employment: School of Computer Science and Engineering, University of Electronic Science and Technology of China.
Resources from the same session
528P - High-biologically effective dose radiotherapy may improve local control of small cell lung cancer patients with brain metastases: A propensity-matching analysis
Presenter: Qingyang Zhuang
Session: Poster display session
Resources:
Abstract
530P - Prognostic value of C-reactive protein, albumin and C-reactive protein to albumin ratio in small cell lung cancer: A meta-analysis
Presenter: Carla Emille Barbon
Session: Poster display session
Resources:
Abstract
531TiP - CANOPY-A: A phase III, placebo-controlled study of canakinumab as adjuvant therapy in patients (pts) with surgically resected NSCLC
Presenter: Byoung Chul Cho
Session: Poster display session
Resources:
Abstract
532TiP - CANOPY-1: A phase III, placebo-controlled study of pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) with/without canakinumab in untreated patients (pts) with stage IIIB/IIIC-IV NSCLC
Presenter: Daniel Shao Weng Tan
Session: Poster display session
Resources:
Abstract
533TiP - CANOPY-2: A phase III, placebo-controlled study of canakinumab with or without docetaxel in patients (pts) with NSCLC previously treated with PD-(L)1 inhibitors and platinum-based chemotherapy (Ctx)
Presenter: Darren Lim
Session: Poster display session
Resources:
Abstract
534TiP - A randomized phase III study of carboplatin plus nab-paclitaxel with or without nintedanib for NSCLC with IPF (J-SONIC)
Presenter: Kohei Otsubo
Session: Poster display session
Resources:
Abstract
535TiP - Phase II study of atezolizumab for pretreated advanced / recurrent non-small cell lung cancer with idiopathic interstitial pneumonia (TORG1936 / AMBITIOUS study)
Presenter: Satoshi Ikeda
Session: Poster display session
Resources:
Abstract
536TiP - INSIGHT 2: Tepotinib plus osimertinib in patients with EGFR-mutant NSCLC having acquired resistance to EGFR TKIs due to MET-amplification: A phase II trial in progress study
Presenter: James C-H Yang
Session: Poster display session
Resources:
Abstract
YO8 - Carcinosarcoma of the Breast in a Filipino Female: A Case Report
Presenter: Ma. Angelle Lalaine Dantes
Session: Poster display session
Resources:
Abstract
YO9 - Small Malignant Phyllodes Tumor of the Breast with Metastases to the Lung and Bone
Presenter: Gusti Harti
Session: Poster display session
Resources:
Abstract